RecurIndex Predicts Risk of Recurrence in Early-stage Luminal Breast Cancer

Not yet recruitingOBSERVATIONAL
Enrollment

500

Participants

Timeline

Start Date

July 31, 2021

Primary Completion Date

May 31, 2025

Study Completion Date

November 30, 2025

Conditions
Breast CancerRecurrence
All Listed Sponsors
lead

Zhejiang Cancer Hospital

OTHER